Mónica Piquer Gibert
Investigador
Research group
Professional network profiles
Last Publications
- Domínguez-Sánchez O, Riggioni, C, Elisabet Poyatos Cantón, Jiménez-Feijoo R, Piquer-Gibert M, Machinena A, Folque, M, Ortiz de Landazuri, I, Torradeflot, M, Lozano-Blasco J, Alsina L, Pascal, M and Alvaro-Lozano M Biomarkers of Tolerance to Baked Milk in Cow's Milk-Allergic Children at High Risk of Anaphylaxis JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY . 36(1): 36-46.
- Domínguez-Sánchez O, Elisabet Poyatos Cantón, C Riggioni, Salamanca G, Jiménez-Feijoo R, Lozano-Blasco J, Piquer-Gibert M, Machinena A, Folqué-Giménez MM, Ortiz de Landazuri I, Lasa M, Alsina L, Pascal M and Alvaro-Lozano M Baked Milk Modulates Cow's Milk Allergy in Children: Impact of Phenotype, Age, and Intake. Journal of Allergy and Clinical Immunology-In Practice . 13(9): .
- Valdesoiro-Navarrete L, Piquer-Gibert M, Menchon, NM, Pinto-Fernández, C, García-Magán, C, Claver-Monzón, A, Thorndike-Piedra, F, Valero, CB, Fernández, SP, Prieto-del-Prado, A, Ortega-Bernal, G and Aragones, AM IgE-mediated allergy to egg protein. ALLERGOLOGIA ET IMMUNOPATHOLOGIA . 53(4): 157-168.
Projects
- Project name:
- Tratamiento proactivo mediante inmunomodulación precoz, con dosis baja y fija de huevo cocido en pacientes de 6 meses a 6 años con alergia al huevo.
- Leader
- Mónica Piquer Gibert
- Funding entities:
- Sociedad Española de Inmunología Clínica, Alergia y Asma Pediátrica
- Code
- PCP00500
- Starting - finishing date:
- 2026 - 2028
- Project name:
- Estudio del efecto de la exposición intrauterina a fármacos anti-TNF-α en el sistema inmunitario de hijos de madres con enfermedades reumáticas inflamatorias
- Leader
- Laia Alsina Manrique de Lara
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI18/00223
- Starting - finishing date:
- 2019 - 2023
- Project name:
- Factores moduladores de la inmunodeficiencia primaria con susceptibilidad a las infecciones graves por gérmenes intracelulares en la edad pediátrica.
- Leader
- Laia Alsina Manrique de Lara
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI15/01094
- Starting - finishing date:
- 2016 - 2020
News
-
The size of the corpus callosum could be a possible biomarker for neurodevelopment in fetuses with congenital heart diseases
Research shows that children with congenital heart defects have a smaller corpus callosum at 32-36 weeks of gestation. BCNatal - Fetal Medicine Research Center, formed by professionals from the Institut de Recerca Sant Joan de Déu (IRSJD) and IDIBAPS, leds this research.
